AST-VAC1

Positive New, Long-Term Follow-Up Data of Asterias Biotherapeutics' AST-VAC1 Cancer Vaccine Demonstrates Prolonged Relapse-Free Survival in Patients with High-Risk Acute Myelogenous Leukemia (AML)
Yahoo
Mon, 06/1/15 - 09:58 am
Asterias
AST-VAC1
AML
acute myelogenous leukemia
Asterias Biotherapeutics Announces Phase 2 Clinical Data on Autologous Telomerase-based Dendritic Cell Cancer Vaccine AST-VAC1
Yahoo
Tue, 04/21/15 - 09:25 am
Asterias
clinical trials
AST-VAC1
vaccines
AML